June 06, 2025

Lower-Dose Treatment Effective in Anal Cancer Trial, Study

In a recent clinical trial, researchers found that a reduced-dose chemoradiotherapy regimen for early-stage anal cancer may be comparable to standard treatment in achieving short-term tumor response, while causing fewer serious side effects.

Conexiant

June 06, 2025

Tarlatamab Improves Survival in Resistant Lung Cancer

A multinational phase 3 trial found that tarlatamab significantly improved overall survival and reduced toxicity compared with standard chemotherapy in patients with small-cell lung cancer after progression on platinum-based therapy.

Conexiant

June 06, 2025

NRT’s Double-Edged Sword in Rectal Cancer

A large cohort study found neoadjuvant radiotherapy improved survival for rectal cancer patients but significantly increased the risk of permanent diverting stomas—especially in upper rectal tumors.

Conexiant

June 06, 2025

Abbreviated MRI Matches Accuracy, Study Finds

A study involving women with dense breast tissue found that an abbreviated breast MRI protocol was as effective as the full version in detecting cancer—while taking less than half the time to complete.

Conexiant

June 04, 2025

Baptist Health Researchers Map How Radiation Rewires the Brain

New research connects changes in brain networks after radiotherapy to declines in memory and cognition.

Baptist Health South Florida

May 30, 2025

Steroid Injections Show More Knee OA Damage

A new study analyzed MRI data from over 200 participants to compare how corticosteroid and hyaluronic acid knee injections affect osteoarthritis progression, revealing distinct differences in joint deterioration over two years.

Conexiant

May 30, 2025

Major Medical Societies Issue GLP-1 Nutrition Guidelines

New advisory addresses nutritional challenges and side effects for obesity treatment

Conexiant

May 23, 2025

New Inhaled Treprostinil Option Approved

Yutrepia represents an additional therapeutic option within the prostacyclin class for the management of PAH and PH-ILD.

Conexiant

May 23, 2025

Patients With Psoriasis Show Inflammation Despite Skin Clearance

Over one-third of psoriasis patients had elevated hs-CRP despite biologic treatment and skin clearance, with obesity, female sex, and fatty liver disease identified as key predictors of residual inflammation.

Conexiant